Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Ross I. Wagner's research has focused on health-related factors in specific patient populations. He has investigated the impact of hydroxyurea starting dose on pain outcomes for individuals with sickle cell disease. Wagner also examined factors associated with an increased risk of vitamin B12 deficiency in patients with type 2 diabetes mellitus who are taking metformin. His work has resulted in 63 publications, with a total of 776 citations and an h-index of 15. He has collaborated with Jacob T. Painter and Kaci Boehmer, both at the University of Arkansas for Medical Sciences, on multiple publications.
Metrics
- h-index: 15
- Publications: 63
- Citations: 780
Selected Publications
-
Factors associated with an increased risk of vitamin <scp>B<sub>12</sub></scp> deficiency in patients with type 2 diabetes mellitus on metformin (2024)
Collaboration Network
Top Collaborators
- Factors associated with an increased risk of vitamin <scp>B<sub>12</sub></scp> deficiency in patients with type 2 diabetes mellitus on metformin
- Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease
- Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease
- Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease
- Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease
- Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease
- Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease
- Factors associated with an increased risk of vitamin <scp>B<sub>12</sub></scp> deficiency in patients with type 2 diabetes mellitus on metformin
- Factors associated with an increased risk of vitamin <scp>B<sub>12</sub></scp> deficiency in patients with type 2 diabetes mellitus on metformin
Similar Researchers
Based on overlapping research topics